ABOUT ELITE
Overview
Our Facility
Management & Key Employees
Our Board
Careers
PRODUCTS
PIPELINE
Generic
Branded
Co-Development
TECHNOLOGY
Technology Overview
How It Works
One Bead System
Two Bead System
INVESTOR RELATIONS
Press Releases
Events & Presentations
SEC Filings
Annual Shareholder Meeting
Governance Documents
Investor Contacts
Email Alerts
Hello world!
Elite Pharmaceuticals Awarded Second Canadian Patent for Abuse Deterrent Drug Formulation
ELITE PHARMACEUTICALS REPORTS SUCCESSFUL PIVOTAL BIOEQUIVALENCE STUDY FOR ABUSE-DETERRENT OXYCODONE PRODUCT ELI-201
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2015
ELITE PHARMACEUTICALS ANNOUNCES NEW MANAGEMENT APPOINTMENTS
Back to top
mobile
desktop